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Abstract: The existence of multiple kinds of estrogen receptors (ERs), involved in independent groups of responses, allows their dissociation and opens the 
possibility to selectively induce beneficial responses but not those considered at risk (cell proliferation). Based on the low hormone-dependent cancer mortality 
in Eastern Asia, attributed to high dietary intake of estrogenic isoflavones, we investigated whether genistein (G) or soybean extracts (S) selectively induce 
some, but not all estrogenic responses in the rat uterus, comparing its activity to that of estradiol-17  (E2). Prepubertal rats were treated with E2, G, 
concentrated S (Sc), diluted S (Sd), or vehicle, and uterine responses to estrogen were evaluated. Luminal epithelial and myometrial cell hypertrophy, and 
luminal epithelial RNA increase, were induced by E2, G or S. Uterine eosinophilia, endometrial edema and proliferation of 4 uterine cell-types were induced 
by E2 only. Results reveal that G and S induce some responses to estrogen but not others, suggesting their use as agents not displaying carcinogenic risk. 
 
Keywords: estrogen, estradiol, genistein, soy extracts, uterus, selective stimulation. 
 
Resumen: La existencia de múltiples tipos de receptores de estrógeno (ERs), involucrados en el desarrollo de grupos independientes de respuestas a 
estrógeno, permite su disociación y abre la posibilidad de inducir en forma selectiva respuestas benéficas pero no aquellas consideradas de riesgo (proliferación 
celular). Basado en la baja mortalidad por cánceres hormono-dependientes en el Este Asiático, atribuidos a una alta ingesta dietaria de isoflavonas 
estrogénicas, nosotros investigamos si la genisteína (G) o extractos de soja (S) inducen en forma selectiva algunas, pero no todas, las respuestas estrogénicas en 
el útero de rata, comparando su actividad con la del estradiol-17β (E2). Ratas prepuberales fueron tratadas con E2, G, S concentrado (Sc), S diluido (Sd) o 
vehículo, y las respuestas estrogénicas en el útero fueron evaluadas. Las hipertrofias celulares en epitelio luminal y miometrio, y el aumento de ARN en células 
del epitelio luminal fueron inducidas por E2, G o S. La eosinofilia uterina, el edema en estroma endometrial y la proliferación de 4 tipos celulares uterinos 
fueron inducidos sólo por E2. Los resultados revelan que G y S inducen algunas respuestas estrogénicas pero no otras, sugiriendo su uso terapéutico como 
agentes estrogénicos que no presentan riesgo de cáncer.  
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INTRODUCTION 
 It is generally accepted that hormonal 
replacement therapy in postmenopausal women, 
besides many beneficial therapeutic effects, increases 
the risk of breast or endometrial cancer, at least after 
a prolonged treatment (Lyytinen et al., 2006). This 
effect seems to be caused by target organ cell 
proliferation stimulation by estrogens used in 
hormone replacement therapy. Therefore, the finding 
of a compound mimicking beneficial responses to es-
trogen but not inducing cell proliferation is desirable. 
If all responses to estrogen were mediated by 
the same mechanism and all ERs were identical, as it 
was first proposed for the cytosol-nuclear receptor-
mediated genomic responses (Jensen & DeSombre, 
1972), the possibilities to selectively induce thera-
peutically convenient responses to estrogen, but not 
those at risk (cell proliferation), would be scarce. 
Up to now, the existence of at least two ERs, 
namely ERα and ERβ, is accepted (Kuiper et al., 
1996; Wang et al., 1999; Damdimopoulos et al., 
2008). However, several authors proposed that some 
of the responses to estrogen could be mediated by 
different kind of ERs. The earliest reports in this 
direction came from our Laboratories, describing 
estrogen binding by eosinophil leukocytes 
(Tchernitchin, 1967, 1973, 1979; Tchernitchin & 
Chandross, 1973). Further, it was proposed that the 
early migration of eosinophil leukocytes to the uterus 
under estrogen stimulation (Tchernitchin et al., 
1974a), and several other non genomic responses to 
estrogen (Tchernitchin, 1983; Tchernitchin et al., 
1985b, 1989) could be related to estrogen binding by 
the eosinophils (Tchernitchin, 1972; Tchernitchin et al., 
1974b), through a novel mechanism (Tchernitchin, 
1979; Galand et al., 1985; Tchernitchin et al., 1985b, 
1989; Grunert et al., 1986; López et al., 1986). Other 
authors also proposed the existence of additional 
estrogen receptors (or binding proteins) and different 
mechanisms for hormonal action: cytoplasmic 
membrane ERs (Pietras & Szego, 1980; Nenci et al., 
1981), type II cytoplasmic and nuclear ERs 
(Markaverich et al., 1981) and specific antiestrogen 
receptors (Sutherland et al., 1980). 
The scene for hormone action is dramatically 
complex, however, it offers the possibility to induce 
separate responses to hormone administration by 
considering the kind of receptors involved or the 
mechanisms surrounding the estrogen responses. This 
dissociation of estrogenic responses was reported 
under the action of several agents or conditions: (a) 
the route of estrogen administration, allowing 
physiological hormone levels only locally or both 
locally and systemically (Tchernitchin & Galand, 
1983); (b) the use of different estrogenic compounds, 
such as estriol (Tchernitchin et al., 1975b), estradiol-
17  (Tchernitchin et al., 1989), diethylstilbestrol 
(Grunert et al., 1986), clomiphene (Grunert et al., 
1987), nafoxidine (Galand et al., 1984, 1985), 2(OH)-
estradiol-17  or 4(OH)estradiol-17  (Baumann et al., 
1986); (c) the interaction with other hormones such 
as glucocorticoids (Tchernitchin et al., 1975a), 
progesterone (Grunert et al., 1984b), insulin 
(Steinsapir et al., 1982a) or thyroid hormones 
(Steinsapir et al., 1982b) ); (d) the administration of 
various pharmaceuticals or biological reagents such 
as teophylline (Steinsapir et al., 1982c), bromocrip-
tine (Unda et al., 1999); actinomycin D (Tchernitchin 
& Galand, 1982) or colloidal carbon (López et al., 
1986); and (e) the exposure to environmental 
pollutants such as lead (Tchernitchin et al., 2003) or 
cadmium (Tchernitchin et al., 2008). This dissoci-
ation opens a therapeutic approach, to selectively 
induce required responses of estrogen stimulation, 
without the simultaneous induction of responses 
considered at risk (endometrial or mammary cell 
proliferation). 
The basis for the present study were reports 
of a lower incidence of several hormonally dependent 
cancers in Asian women than in Western women 
(Adlercreutz, 2002a); this difference in incidence 
parallels the significantly higher amount of 
phytoestrogens – including soybean products – 
consumed by Eastern Asian women (Adlercreutz, 
2002a; Wang & Murphy, 1994). Second- and third-
generation descendants of women who migrated from 
Asia to Western countries have hormonally-
dependent cancer risks similar to those of women in 
the host country, suggesting that lifestyle but not 
genetic factors could explain the lower cancer risk 
observed in women living in Asia (Probst-Hensch et 
al., 2000; Usui, 2006). In East and Southeast Asia the 
average intake of phytoestrogens is estimated to be 
more than ten times higher than in the United States 
or Europe (Adlercreutz, 2002b), and plasma 
isoflavone concentrations are higher in Japanese 
women than in Europeans, suggesting the possibility 
of their role in hormonally-dependent cancer 
prevention (Messina et al., 1994; Mense et al., 2008). 
Based on the above evidence, the aim of the 
present study was to investigate the agonistic 
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estrogenic activity of G and S in the prepubertal rat 
uterus in vivo. In this model, we intended to find out 
whether these compounds are able to selectively 
induce some but not all responses to hormone 
stimulation in the uterus, for their potential use as 
therapeutic agents for hormonal replacement therapy 
devoid of hormonally-dependent cancer risk, at least, 
in the uterus. 
MATERIALS AND METHODS 
Plant extracts, Phytoestrogens amd Hormones 
 Commercially available soybean Glycine 
max (L.) Merr. (Leguminosae) extract Solgen 40 was 
purchased from Solbar Plant Extracts, Ashdod, Israel. 
It contained 43.87% total isoflavones; 69% of total 
isoflavones were in genistin form. Pure genistein 
HPLC standard quality was purchased from Sigma. 
and estradiol-17β was purchased from Merck.  
Experimental Animal Procedure 
The experimental protocol was approved by 
the local Ethical Committee. 
Sprague-Dawley rats were breaded and 
maintained in the vivarium of the University of Chile 
School of Medicine. 
Female prepubertal (21-day-old) animals 
were treated s.c. with the vehicle (C) (0.3 mL 1:9 
ethanol/ saline), estradiol-17  (E2) Merck (0.33 
mg/kg b.wt.), genistein (G) Sigma (0.5 mg/kg b.wt.) 
or two different concentrations of Solgen 40 soybean 
ethanol extracts (S): diluted S (Sd) (0.06 mg 
genistin/kg) and concentrated S (Sc) (0.364 mg 
genistin/kg b.wt.). The dose of E2 was chosen from 
former studies in the same prepubertal rat model, 
assuring the maximal responses to hormone 
stimulation for all analyzed parameters of hormone 
stimulation in the uterus (Tchernitchin et al., 1975b, 
Grunert et al., 1986, 1987). The dose of G and the 
highest dose of S were chosen to assure an 
approximation to estradiol molar concentrations 
inducing the maximal response to hormone 
stimulation (0.01-0.3 mg/kg). Both doses of S were 
used to verify whether there were differences in the 
effects in the different uterine cell-types due to 
hypothetical presence of additional active agents in 
the extracts. Genistin quantification was based in the 
indirect valoration of G following 2M HCl hydrolysis 
and G quantification by HPLC (Franke et al., 1994; 
Irvine et al., 1998). The prepubertal rat model was 
chosen since the very low endogenous estrogen levels 
in control animals assure absence of estrogenic 
responses; at that age all estrogen receptors and 
mechanisms were reported fully responding to 
hormone stimulation (Tchernitchin et al., 1980). 10 
rats were used for each of the 10 experimental 
conditions. 
Uteri were excised under ether anesthesia 6 
or 24 h after treatment and fixed in neutral formalin 
for further histological process. 
Histological, Histochemical and Morphometrical 
Procedure 
Each uterine formalin fixed and dehydrated 
horn was cut in three pieces (superior, medium and 
caudal), that were paraffin-embedded together in a 
single paraffin block, so that 5 μm thick uterine cross 
sections from the above three pieces could be 
observed together in the same histological slide and 
evaluated all of them. 
For each animal, one group of hydrated 
uterine cross sections was stained 1-3 min in 
hematoxylin, washed in several changes of tap water, 
and then quickly transferred to a saturated lithium 
carbonate solution, where they were kept for 1 min. 
Subsequently, they were stained in 1% eosin y 
aqueous solution, washed quickly in distilled water, 
and dehydrated in a graded series of ethyl alcohols, 
absolute ethanol and xylene (Grunert et al., 1984a). 
This procedure was used for eosinophil quantification 
(Tchernitchin et al., 1974a, 1985a), mitoses counting 
in the different uterine cell types (Grunert et al., 
1986, 1987) morphometry (Grunert et al., 1984a), 
including computer assisted image analysis of 
luminal epithelial cell volume (Tchernitchin et al., 
2003). Another group of hydrated uterine cross 
sections was stained with phosphate-buffered 0.01% 
acridine orange (pH 7.4) in distilled water for 5 min, 
differentiated in 0.1% (wt/v) calcium chloride and 
covered with phosphate buffer (pH 7.4). This stain 
allows RNA and DNA densitometry with a 
epifluorescence microscope under excitation light, λ 
380-420 nm (Konarev, 1966).  
Quantification of estrogenic responses 
The following estrogenic responses were 
quantified in the uterus: uterine eosinophilia, 
percentage of eosinophils according to the 
distribution in different uterine histological layers 
and to their degree of degranulation; edema in deep 
endometrial stroma; luminal epithelial cell RNA 
content, luminal epithelial and myometrial cell 
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hypertrophy, and number of mitotic figures in 
luminal epithelium, glandular epithelium, 
endometrial stroma and myometrium. 
 
Figure 1. Effect of a treatment with estradiol-17ß, or 
phytoestrogens on myometrial (Fig 1A) and endometrial luminal 
epithelial (Fig. 1B) cell hypertrophy and on RNA content 
increase in endometrial luminal epithelial cells (Fig. 1C) 
 
 
Prepubertal rats received s.c. 0,33 mg estradiol-17ß /kg b.wt (E), 
0,5 mg genistein/kg b.wt. (G), soybean extract containing 0.06 
mg genistin/kg b.wt.(Sd) or 0.364 mg genistin/kg b.wt. (Sc), or 
vehicle (C), and the uteri were excised 24 h thereafter under 
anesthesia. Bars indicate means (expressed as % of response to 
estradiol) ± standard error of the mean. Statistics: least significant 
difference a posteriori LSD test. +, p<0.05, **, p<0.01; **** or 
++++, p<0.0001; *, comparisons to vehicle-treated controls; +, 
comparisons to estradiol-treated animals 
The various parameters of estrogen 
stimulation were evaluated at times their maximal 
response occurs (Tchernitchin et al., 1974a, 2003; 
Grunert et al., 1984a). Uterine eosinophilia reaches 
maximal response at 6 or 24 h, endometrial edema 
reaches maximal response at 6 h and declines 
thereafter, uterine luminal epithelial RNA content, 
luminal epithelial and myometrial cell hypertrophy 
and uterine luminal epithelial, glandular epithelial, 
stromal and myometrial cell proliferation reach 
maximal level responses at 24 h after treatment. 
 
Figure 2. Effect of a treatment with estradiol-17ß or 
phytoestrogens on edema in deep endometrial stroma (Fig. 2A) 
and uterine eosinophilia (Fig. 2B). 
 
Prepubertal rats received s.c. 0,33 mg estradiol-17ß /kg b.wt (E), 
0,5 mg genistein/kg b.wt. (G), soybean extract containing 0.06 
mg genistin/kg b.wt.(Sd) or 0.364 mg genistin/kg b.wt. (Sc), or 
vehicle (C), and the uteri were excised 6 h thereafter under 
anesthesia. In Fig. 2A (edema in deep endometrial stroma) bars 
indicate means from non-transformed data (expressed as % of 
response to estradiol) ± standard error of the mean. In Fig. 2B 
(uterine eosinophilia) bars indicate geometric means from log-
transformed data (expressed as % of response to estradiol) ± 
standard error of the mean. Statistics: least significant difference 
a posteriori LSD test. *, p<0.05; *** or +++, p<0.001; **** or 
++++, p<0.0001; *, comparisons to vehicle-treated controls; +, 
comparisons to estradiol-treated animals 
 
 
To allow a comparison between the effects of 
genistein or soy extracts among the different 
parameters of estrogen stimulation, all responses 
were expressed as % of maximal response, i.e., the 
value of vehicle-treated animals was considered as 
0% response, and the value of maximal response to 
E2 – 100% response. 
For each animal, uterine eosinophilia 
(Tchernitchin et al., 1974a) was assessed in 30 
uterine sections, distributed along the uterus 
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(proximal, medial and caudal); eosinophils were 
classified according to their location within the 
different uterine histological layers and to their 
degree of degranulation (Tchernitchin et al., 1985a; 
Grunert et al., 1986). 
Edema in deep endometrial stroma (Grunert 
et al., 1984a) was evaluated by counting number of 
nuclei in 36 1054 μm2 areas delimited by a standard 
circle located in the ocular piece of the microscope. 
As demonstrated in earlier reports (Grunert et al., 
1984a), an increase in the reciprocal value of cell 
density (a decrease in cell counts within a standard 
area) in a location containing few cells and mainly 
extracellular space, reflects edema since an increase 
in its volume, but not in the cellular volume, traduces 
in an increase in the reciprocal value of cell density. 
Myometrial cell hypertrophy (Grunert et al., 
1984a) was also evaluated by counting the number of 
nuclei in 36 standard areas; previous reports (Grunert 
et al., 1984a) show that an increase in the reciprocal 
value of cell density in this location containing cell 
bodies and where extracellular space is negligible, 
reflects increase in  cell size but not extracelullar 
edema. 
Luminal epithelial cell hypertrophy was 
evaluated from digital micrographs from luminal 
epithelium, where cell limits were marked around 
groups of well defined epithelial cells boundaries; 80 
cells were measured in each animal, using computer 
assisted image analysis to calculate luminal epithelial 
cell volume (Tchernitchin et al., 2003). 
Luminal epithelial RNA content was 
evaluated from digital micrographs of acridine 
orange stained uterine sections, with an 
epifluorescence microscope Nikon EFD-3 under 
excitation light, λ 380-420 nm, using computer 
assisted morphometry and cell densitometry 
(Tchernitchin et al., 2003). 80 cells were measured 
for each animal. 
Estrogen-induced mitotic response was 
evaluated as an increase in the number of mitotic 
figures in luminal epithelium, glandular epithelium, 
endometrial stroma and myometrium, and quantified 
for each animal in 18 uterine cross sections 
considering all three uterine pieces (Grunert et al., 
1986, 1987).  
Statistics 
According to previous studies (Grunert et al., 
1986) using the Tukey test of additivity (Snedecor & 
Cochran, 1967), data on some parameters of estrogen 
stimulation needs to be submitted to logarithmic or 
square root transformation to normalyze data 
distribution. Accordingly, the log-transformation was 
performed on uterine eosinophil numbers, RNA 
content in luminal epithelial cells, and luminal 
epithelial cell volume (Grunert et al., 1986). 
Transformed (above responses to estrogen) and non-
transformed (all other parameters of estrogen 
stimulation in the uterus) data were subjected to 
further statistical analysis. 
Since multiple comparisons were performed 
between the different experimental conditions, 
transformed and non-transformed data were subjected 
to the least significant difference a posteriori (LSD) 
test. The common variance needed for this test was 
estimated from a one-way unbalanced analysis of 
variance (ANOVA). 
In uterine eosinophil degranulation and 
distribution proportion studies, the χ2 statistic was 
used to evaluate differences between the proportions. 
The percentage of degranulation and of eosinophils 
located in the various histological layers of the uterus 
were no considered in some experimental animals 
(i.e., control animals without estrogen treatment) due 
to the extremely low number of eosinophils in these 
experimental conditions, that does not allow a valid 
statistical analysis. 
RESULTS  
Cell hypertrophy and cell RNA content increase. 
Myometrial hypertrophy was induced by E2, 
G and two concentrations of S. While hypertrophy 
reached with G or Sc was similar to that induced by 
E2, response reached with Sd was about half of that 
reached with E2 (Fig. 1A). Endometrial luminal 
epithelial cell hypertrophy (Fig. 1B) and RNA 
content (Fig. 1C) were induced by E2, G and both S. 
While responses similar to E2 were achieved by G 
only; the responses to Sc or Sd were about half of 
that obtained with E2.  
 
Endometrial edema and uterine eosinophilia. 
Edema in deep endometrial stroma was 
induced by E2 only (Fig. 2A). A normal intensity 
estrogen-induced uterine eosinophilia was observed 
following E2 treatment only, although a very slight 
but statistically significant response was also 
observed with the Sd (Fig. 2B). Eosinophil 
degranulation was significantly weaker with the Sd as 
compared to E2 (Fig. 3A). As compared to E2-treated 
animals where most uterine eosinophils were located  
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Figure 3. Effect of a treatment with estradiol-17ß or phytoestrogens on the proportions of degranulated and non-degranulated uterine 
eosinophils (Fig. 3A) and the proportions of uterine eosinophils located in the mesometrium and in the endometrium with myometrium (Fig. 
3B). 
 
Prepubertal rats received s.c. 0,33 mg estradiol-17ß /kg b.wt (E), 0,5 mg genistein/kg b.wt. (G), soybean extract containing 0.06 mg 
genistin/kg b.wt.(Sd) or 0.364 mg genistin/kg b.wt. (Sc), or vehicle (C), and the uteri were excised 6 h thereafter under anesthesia. The 
proportions in controls are not shown because of the extremely low eosinophil numbers, which does not allow any valid statistical analysis. 
Statistics: χ2 test; +++, p<0.001; comparisons to estradiol-treated animals. 
 
Figure 4. Effect of a treatment with estradiol-17ß or phytoestrogens on the number of mitotic figures in endometrial luminal epithelium (Fig. 
4A), endometrial glandular epithelium (Fig. 4B), endometrial stroma (Fig. 4C) and myometrium (Fig. 4D). 
 
Prepubertal rats received s.c. 0,33 mg estradiol-17ß /kg b.wt (E), 0,5 mg genistein/kg b.wt. (G), soybean extract containing 0.06 mg 
genistin/kg b.wt.(Sd) or 0.364 mg genistin/kg b.wt. (Sc), or vehicle (C), and the uteri were excised 24 h thereafter under anesthesia. Bars 
indicate means (expressed as % of response to estradiol) ± standard error of the mean. Statistics: least significant difference a posteriori LSD 
test. *** or +++, p<0.001; **** or ++++, p<0.0001; *, comparisons to vehicle-treated controls; +, comparisons to estradiol-treated animals. 
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in endometrium with myometrium, in S-treated 
animals there were more eosinophils in the 
mesometrium, and following G treatment all the 
eosinophils were in the mesometrium (Fig 3B).. 
Eosinophil degranulation and distribution within the 
uterine histological layers data is not shown in 
control animals because of the extremely low 
eosinophil counts that do not allow any valid 
statistical analysis.  
 
Uterine cell proliferation. 
Uterine cell proliferation (Fig 4), was 
induced in uterine luminal epithelium (Fig. 4A), 
uterine glandular epithelium (Fig. 4B), endometrial 
stroma (Fig. 4C) and myometrium (Fig. 4D) by E2 
only, but not by G or the soy extracts.  
DISCUSSION 
Present results reveal a dissociation of 
estrogenic responses by either G and S. While the 
increase in RNA content in luminal epithelial cells 
and cell hypertrophy in luminal epithelial and 
myometrial cells were strongly induced by E2, G, Sd 
or Sc, uterine eosinophilia, endometrial edema and 
cell proliferation in luminal epithelium, glandular 
epithelium, endometrial stroma and myometrium 
were induced by E2 only, but not by G or S.  
A myriad of explanations may be 
proposed to explain the selective induction of 
just some responses to estrogen but not others. 
Subtle differences in ER conformations caused by 
interaction with different ligands, which interact with 
different co-activators or co-repressors within the cell 
(Charlier et al., 2009). Presence of different 
molecular chaperones eg FKBP51, FKBP52, Cyp40, 
which may be incorporated in the inactivated ER 
complexes from the different cell types (Reynolds et 
al., 1999; McKeen et al., 2010). Or the existence of 
different kind of ERs mediating different responses to 
hormone stimulation (Tchernitchin 1972, 1983; 
Galand et al., 1985; Tchernitchin et al., 1985b, 1989; 
Grunert et al., 1986; López et al., 1986). Present 
results, do not disagree with any of the above 
hypotheses. According to our hypothesis, some 
receptors may display high affinity for any specific 
phytoestrogens while other receptors may display 
low affinity for the same compounds, explaining the 
induction of some responses only. Alternatively to 
the above explanations, it is possible to speculate that 
the effects of G and/or S are not responses mediated 
by ERs. To evaluate this possibility, a possible 
antagonistic effect of these agents on receptor 
mediated responses to estrogen is currently 
investigated. Preliminary results from experiments 
with coadministration of G and E2 suggest 
competitive interaction with responses induced by E2 
(manuscript in preparation).  
The absence of estrogen induced uterine 
eosinophilia, and one of the responses proposed to be 
mediated by the eosinophils in the uterus 
(endometrial edema), may be explained by the lack of 
recognition of the mesometrium vascular 
endothelium by the eosinophils - the main site of 
migration of eosinophils towards the uterus (Soto et 
al., 1979) - or by the decrease in eosinophils mobility 
through uterine extravascular space towards 
myometrium and endometrium. It was suggested that 
eosinophil recognition of uterine (mainly 
mesometrial) endothelium is a process mediated by 
high affinity ERs located in the surface of the 
eosinophils (Tchernitchin et al., 1985b). The lack of 
recognition of the uterine mesometrium may be 
explained either by a low affinity displayed by the 
phytoestrogen for this receptor or by its antagonist 
action. An inhibition of eosinophil redistribution 
through the uterus from mesometrium, observed in 
the present study (increased proportion of eosinophils 
remaining in the mesometrium in animals treated 
with Sc, Sd or G) may be explained by the decrease 
in eosinophil degranulation that was observed in Sc 
treated rats, taking into consideration that hydrolytic 
enzyme released from degranulating eosinophils are 
required for eosinophil migration through uterine 
ground substance (Grunert et al., 1984b; Tchernitchin 
et al., 1985b, 1989).  
A comparison of luminal epithelium and 
myometrium also reveals differences under the effect 
of different concentrations of S. In  the myometrium, 
while Sc induced a full cell hypertrophy similarly to 
E2, in luminal epithelium Sc induced a much weaker 
cell hypertrophy or RNA content increase than E2. 
This may reflect a difference between luminal 
epithelium and myometrial ERs, displaying different 
affinities for some of the S active components, or a 
possible competitive inhibition by glycones or other 
phytoestrogens present in the extracts. The soybean 
ethanol extracts mainly contain the glucoside 
genistin, which is supposed to be devoid of 
estrogenic activity since it most probably does not 
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enter the intracellular space. Soybean genistin taken 
orally hydrolyzes in the intestine to its aglycone form 
genistein and enters circulation as such (Kelly et al., 
1995), displaying estrogenic activity (Zhang et al., 
1999). Further studies are necessary to evaluate this 
possibility, and investigate whether part of the 
genistin is hydrolized in the tissue to release the 
aglycone or other metabolites. 
Irrespectively to the mechanisms involved in 
the interaction of G or S with the uterus, the 
dissociation of estrogenic responses by 
phytoestrogens suggests their possible therapeutic 
application to induce clinically needed responses 
without inducing risk responses. Estrogen-induced 
cell proliferation is the main risk side effect for 
hormone replacement therapy in postmenopausal 
women, which may initiate or stimulate tumour 
growth. Therefore, absence of cell-proliferation in 
uterine luminal epithelial, glandular epithelial cells, 
endometrial stroma and myometrium by S and by G 
itself, suggests they do not share the estrogens’ 
increased risk for cancer development in 
postmenopausal women, at least in the uterus. Further 
studies are needed to investigate the effects of G and 
S in other estrogen target organs. 
CONCLUSIONS 
Present results reveal, for the first time, a 
dissociation of responses to estrogen by 
phytoestrogens, While estradiol induces an increase 
in RNA content in luminal epithelial cells, cell 
hypertrophy in luminal epithelial and myometrial 
cells, uterine eosinophilia, endometrial edema and 
cell proliferation in luminal epithelium, glandular 
epithelium, endometrial stroma and myometrium, G 
and S only induce an increases in RNA content in 
luminal epithelial cells and cell hypertrophy in 
luminal epithelial and myometrial cells, but not the 
remaining estrogenic responses. 
The selective induction of some estrogenic 
responses but not others under the effect of G and S 
suggests their possible therapeutic application as 
agents not inducing cell proliferation in the uterus, 
therefore, not displaying the increased risk of cancer 
development in this organ. Work is in progress to 
evaluate the expression of apoptotic proteins such as 
Ki67 as well as the expression of estrogen receptors α 
and β. 
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